首页> 美国卫生研究院文献>World Journal of Clinical Cases >Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques
【2h】

Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques

机译:在新的成像技术和微创技术时代不进行前列腺穿刺活检的前列腺切除术的可行性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDRoutinely, after receiving prostate specific antigen (PSA) testing and digital rectum examination, patients with suspected prostate cancer are required to undergo prostate biopsy. However, the ability of ultrasound-guided prostate biopsy to detect prostate cancer is limited. Nowadays, a variety of diagnostic methods and more sensitive diagnostic methods, such as multi-parameter prostate magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) can be applied clinically. Furthermore, laparoscopic/robot-assisted prostatectomy is also a safe and effective procedure for the treatment of benign prostatic hyperplasia. So maybe it is time to reconsider the necessary to perform prostate biopsy before radical prostatectomy.
机译:背景技术常规地,在接受前列腺特异性抗原(PSA)测试和直肠指检之后,怀疑患有前列腺癌的患者需要进行前列腺活检。然而,超声引导的前列腺活检检测前列腺癌的能力是有限的。如今,可以在临床上应用多种诊断方法和更灵敏的诊断方法,例如多参数前列腺磁共振成像(mpMRI)和前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(PSMA PET / CT)。此外,腹腔镜/机器人辅助前列腺切除术也是治疗良性前列腺增生的安全有效方法。因此,也许是时候重新考虑在根治性前列腺切除术之前进行前列腺穿刺活检的必要性了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号